#DidYouKnow that liver cancer ranks as the sixth most diagnosed cancer worldwide, and the third most common cause of cancer death? Over the next 25 years, predictions indicate that liver cancer instances will continue to rise, perhaps exceeding 1.5 million new cases per year by 2050 (a nearly 70% increase since 2022). Download the report on liver cancer to discover the latest advancements in treatment options. https://lnkd.in/dCJr7scb #LiverCancerAwareness #clinicaltrials #Novotech
Novotech’s Post
More Relevant Posts
-
🌟 Revolutionary Cancer Pill: AOH1996 targets a protein promoting cancer growth, currently in Phase I trials. 🔬 Unique Approach: Blocks PCNA, crucial for cancer cell replication, setting it apart from other treatments. 📚 Promising Results: Effective against various cancers, including lung, breast, and brain. 🧪 Future Impact: AOH1996 could transform cancer treatment, offering new hope. Read the full article here: https://lnkd.in/ewaYncMh #cancerawareness #cancertreatment #cancer #healthcarenews #healthnews
-
-
Today is Lung Cancer Day 🎗️ It is the 3️⃣rd most commonly newly diagnosed cancer in Europe 🇪🇺 but is responsible for the most cancer deaths. The #canSERV_EU project does its part & unites world-class cancer research services in 1️⃣ single platform to bring together an extensive repertoire of technologies to advance the understanding of cancer, diagnosis and treatments approaches for the benefit of cancer patients and their friends and families 🙌 #CancerMission #BeatingCancer #HorizonEU #WLCD23
-
-
A new study found that inherited BRCA2, ATM, and NBN genes were most strongly associated with aggressive or metastatic prostate cancer. Learn more at: https://lnkd.in/epUMiBkr Reference: Darst, et al. JAMA Oncol. 2023. PMID: 37733366. #ICARE #InheritedCancerRegistry #InheritedCancer #HereditaryCancer #Cancer #ProstateCancer #CancerGenetics #GeneticTesting #BRCA2 #ATM #NBN #CancerRisks #CancerRiskManagement #CancerPrevention #CancerEducation #CancerAwareness American Society of Clinical Oncology (ASCO) American Cancer Society National Cancer Institute (NCI) Vanderbilt Health Vanderbilt-Ingram Cancer
-
Colorectal Cancer is the 3rd most common cancer across the World, and it is also the 2nd leading cause of cancer-related deaths. Watch this video short to discover what is Colorectal Cancer, also known as Colon Cancer & ways to diagnose the same. #OncoTalks #colorectal #colorectalcancer #coloncancer #diagnosis #câncer World Health Organization National Cancer Institute (NCI)
-
A simplified introduction on Colorectal Cancer and ways to diagnose by Dr. Sajjan Rajpurohit #colorectalcancer #colorectalcancerawareness #cancerawareness #diagnosis
Colorectal Cancer is the 3rd most common cancer across the World, and it is also the 2nd leading cause of cancer-related deaths. Watch this video short to discover what is Colorectal Cancer, also known as Colon Cancer & ways to diagnose the same. #OncoTalks #colorectal #colorectalcancer #coloncancer #diagnosis #câncer World Health Organization National Cancer Institute (NCI)
-
A ray of hope in cancer research: A melanoma cancer vaccine with minimal side effects is nearing phase 3 trials. 💉🔬 ◾ This promising development could significantly advance melanoma treatment, offering new hope to patients worldwide. ◾ As we navigate the complex landscape of cancer research, each breakthrough brings us one step closer to a cure. 💡🌐 ◾ Join us as we discuss this significant advancement and its potential impact on cancer treatment. #CancerResearch #MelanomaVaccine #MedicalBreakthrough https://lnkd.in/ePRyw8f8
-
Liver Cancer is the 6th most common cancer in the world. People with certain risk factors are more likely to develop primary liver cancer or HCC. The more risk factors a person has, the greater the chance that liver cancer will develop. This post will highlight the risk factors associated with Liver Cancer. If you think you may be at risk for liver cancer, you should discuss it with your doctor early. #CancerAwareness #LiverCancer #HealthFirst #SSO #SSOSingapore #SingaporeSocietyOfOncology
-
-
𝗗𝗶𝗱 𝘆𝗼𝘂 𝗸𝗻𝗼𝘄? According to The National Institutes of Health, liver cancer is the sixth most common cancer and the third leading cause of cancer death. Techsomed is dedicated to making an enhanced clinical impact in liver tumor ablation through our innovative, #AI-powered Image-Guided #Ablation Therapy (IGAT) platform. Join us in raising awareness for liver cancer this October! #LiverCancerAwarnessMonth, #LiverCancer, #HepatocellularCarcinoma #OctoberIs4Livers
-
-
𝗗𝗶𝗱 𝘆𝗼𝘂 𝗸𝗻𝗼𝘄? According to The National Institutes of Health, liver cancer is the sixth most common cancer and the third leading cause of cancer death. Techsomed is dedicated to making an enhanced clinical impact in liver tumor ablation through our innovative, #AI-powered Image-Guided #Ablation Therapy (IGAT) platform. Join me in raising awareness for liver cancer this October! #LiverCancerAwarnessMonth, #LiverCancer, #HepatocellularCarcinoma #OctoberIs4Livers
-
-
A ray of hope in cancer research: A melanoma cancer vaccine with minimal side effects is nearing phase 3 trials. 💉🔬 ◾ This promising development could significantly advance melanoma treatment, offering new hope to patients worldwide. ◾ As we navigate the complex landscape of cancer research, each breakthrough brings us one step closer to a cure. 💡🌐 ◾ Join us as we discuss this significant advancement and its potential impact on cancer treatment. #CancerResearch #MelanomaVaccine #MedicalBreakthrough https://lnkd.in/eXzEFcis
Cancer vaccine with minimal side effects nearing Phase 3 clinical trials
abcnews.go.com
Chief Executive Officer at USA and International Research Inc.
1moKnowledge is power! Thanks for sharing these crucial insights into liver cancer trends and advancements in treatment options.